The VanEck Pharmaceutical ETF ( PPH -0. 07% ) provides a lower-cost entry and higher yield than the Invesco Pharmaceuticals ETF ( PJP -0. 30% ) , which has shown stronger 1-year returns and more concentrated top holdings.
Read the original report for the complete account of this story.
